Center for Bioinformatics, College of Life Science, Northwest A&F University, Yangling, Shaanxi 712100, China.
School of Chemical Engineering, Dalian University of Technology, Dalian, Liaoning 116024, China.
J Cheminform. 2014 Apr 16;6:13. doi: 10.1186/1758-2946-6-13. eCollection 2014.
Modern medicine often clashes with traditional medicine such as Chinese herbal medicine because of the little understanding of the underlying mechanisms of action of the herbs. In an effort to promote integration of both sides and to accelerate the drug discovery from herbal medicines, an efficient systems pharmacology platform that represents ideal information convergence of pharmacochemistry, ADME properties, drug-likeness, drug targets, associated diseases and interaction networks, are urgently needed.
The traditional Chinese medicine systems pharmacology database and analysis platform (TCMSP) was built based on the framework of systems pharmacology for herbal medicines. It consists of all the 499 Chinese herbs registered in the Chinese pharmacopoeia with 29,384 ingredients, 3,311 targets and 837 associated diseases. Twelve important ADME-related properties like human oral bioavailability, half-life, drug-likeness, Caco-2 permeability, blood-brain barrier and Lipinski's rule of five are provided for drug screening and evaluation. TCMSP also provides drug targets and diseases of each active compound, which can automatically establish the compound-target and target-disease networks that let users view and analyze the drug action mechanisms. It is designed to fuel the development of herbal medicines and to promote integration of modern medicine and traditional medicine for drug discovery and development.
The particular strengths of TCMSP are the composition of the large number of herbal entries, and the ability to identify drug-target networks and drug-disease networks, which will help revealing the mechanisms of action of Chinese herbs, uncovering the nature of TCM theory and developing new herb-oriented drugs. TCMSP is freely available at http://sm.nwsuaf.edu.cn/lsp/tcmsp.php.
现代医学经常与传统医学（如中草药）发生冲突，因为人们对草药作用机制的了解甚少。为了促进两者的融合，加速从草药中发现药物，迫切需要一个有效的系统药理学平台，该平台代表了药物化学、药代动力学、药物相似性、药物靶点、相关疾病和相互作用网络等理想信息的融合。
传统中药系统药理学数据库和分析平台（TCMSP）是基于草药系统药理学框架构建的。它包含了中国药典中注册的 499 种中草药，共有 29384 种成分、3311 个靶点和 837 种相关疾病。提供了 12 种重要的药代动力学相关特性，如人体口服生物利用度、半衰期、药物相似性、Caco-2 渗透率、血脑屏障和 Lipinski 的五规则，用于药物筛选和评估。TCMSP 还提供了每个活性化合物的药物靶点和疾病，它可以自动建立化合物-靶点和靶点-疾病网络，使用户可以查看和分析药物作用机制。它旨在为草药的发展提供动力，并促进现代医学与传统医学的融合，以发现和开发药物。
TCMSP 的独特优势在于大量草药条目，以及识别药物-靶点网络和药物-疾病网络的能力，这将有助于揭示中草药的作用机制，揭示中医理论的本质，并开发新的以草药为导向的药物。TCMSP 可在 http://sm.nwsuaf.edu.cn/lsp/tcmsp.php 免费获取。
